MAP microba life sciences limited

Ann: Details of Q4 FY22 Investor Webinar, page-2

  1. 10,126 Posts.
    lightbulb Created with Sketch. 1041
    Looking forward to the quarterly results tomorrow pre market opening.

    With our new major distribution agreements only just signed prior to 30 June I would expect a substantial increase in revenues this time next year.

    I'm expecting circa $4 mil last FY and $20 mil plus for this FY. Heading to $40 mil plus for 2024 FY.

    The revenues are great but the data generation is the secret source to big pharma partnerships.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.3¢
Change
0.001(1.09%)
Mkt cap ! $47.89M
Open High Low Value Volume
9.3¢ 9.3¢ 9.3¢ $2.79K 30K

Buyers (Bids)

No. Vol. Price($)
5 20774 9.2¢
 

Sellers (Offers)

Price($) Vol. No.
9.5¢ 114482 1
View Market Depth
Last trade - 11.50am 30/07/2025 (20 minute delay) ?
MAP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.